Literature DB >> 2419713

Additive and synergistic effects of a novel antiestrogen, toremifene (Fc-1157a), and human interferons on estrogen responsive MCF-7 cells in vitro.

L Kangas, A L Nieminen, K Cantell.   

Abstract

The effect of human interferons alpha and gamma alone and in combination with a novel antiestrogen toremifene were studied in vitro using MCF-7 cell line, an estrogen receptor positive and antiestrogen sensitive cell line. The effects were evaluated by a simple bioluminescence method with which the number of living cells was obtained as cellular adenosine triphosphate (ATP) content. The growth of MCF-7 cells was inhibited both by interferon alpha and interferon gamma. At least additive effect was evident when the cells were exposed to combination of interferons and toremifene: the combination was additive with interferon gamma + toremifene and synergistic with interferon alpha + toremifene. The combination of toremifene and interferons may have clinical importance.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2419713

Source DB:  PubMed          Journal:  Med Biol        ISSN: 0302-2137


  8 in total

1.  Tamoxifen and interferon-beta for the treatment of metastatic breast cancer.

Authors:  L Repetto; P G Giannessi; E Campora; P Pronzato; A Vigani; C Naso; I Spinelli; P F Conte; R Rosso
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection.

Authors:  Pablo Gastaminza; Christina Whitten-Bauer; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-07       Impact factor: 11.205

3.  Androgen receptors and hormone sensitivity of a human prostatic cancer cell line (PC-3) are modulated by natural beta-interferon.

Authors:  G Sica; G Dell'Acqua; F Iacopino; A Fattorossi; P Marchetti; T H van der Kwast; M Pavone-Macaluso
Journal:  Urol Res       Date:  1994

4.  Rationale for combining tamoxifen and interferon in the treatment of advanced breast cancer.

Authors:  F Porzsolt; A M Otto; B Trauschel; C Buck; A W Wawer; H Schönenberger
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

5.  Inhibition of hormone-dependent and independent breast cancer cell growth in vivo and in vitro with the antiestrogen toremifene and recombinant human interferon-alpha 2.

Authors:  S P Robinson; D Goldstein; P L Witt; E C Borden; V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1990-02       Impact factor: 4.872

Review 6.  New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancers.

Authors:  Armel Hervé Nwabo Kamdje; Paul Faustin Seke Etet; Lorella Vecchio; Richard Simo Tagne; Jeremie Mbo Amvene; Jean-Marc Muller; Mauro Krampera; Kiven Erique Lukong
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

7.  Human recombinant interferon-beta SER and tamoxifen: growth suppressive effects for the human breast carcinoma MCF-7 grown in the athymic mouse.

Authors:  D F Gibson; D A Johnson; D Goldstein; S M Langan-Fahey; E C Borden; V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

8.  Recombinant human interferon-alpha 2a increases hormone receptor level of a human breast carcinoma xenograft in nude mice and enhances the anti-proliferative activity of tamoxifen.

Authors:  K Josui; T Kubota; M Kitajima
Journal:  Jpn J Cancer Res       Date:  1992-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.